Childhood choriocarcinoma of the ovary

Summary

Childhood choriocarcinoma of the ovary (MONDO:0004535) is a disease. A subtype of pediatric ovarian germ cell tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	childhood choriocarcinoma of the ovary
Mondo ID	MONDO:0004535
DOID	DOID:8336
NCIT	C6549
UMLS	C1332987
MedGen	234135
GARD	0024052
Is cancer (heuristic)	no

Also known as: childhood choriocarcinoma of ovary · childhood ovarian choriocarcinoma · choriocarcinoma of ovary of childhood · paediatric choriocarcinoma of ovary · paediatric choriocarcinoma of the ovary · paediatric ovarian choriocarcinoma · pediatric choriocarcinoma of ovary · pediatric choriocarcinoma of the ovary · pediatric ovarian choriocarcinoma

Disease family

This is a subtype of pediatric ovarian germ cell tumor. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › germ cell tumor › childhood germ cell tumor › pediatric ovarian germ cell tumor › childhood choriocarcinoma of the ovary

Related subtypes (4): childhood ovarian yolk sac tumor, childhood teratoma of the ovary, pediatric ovarian dysgerminoma, childhood ovarian embryonal carcinoma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.